FHC
XGN icon

First Horizon Corporation’s Exagen XGN Stock Holding History

First Horizon Corporation’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$14K Buy
+958
New +$14.7K ﹤0.01% 621

Other funds holding XGN

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

First Horizon Corporation's XGN Position: Q2 2021 in Review

First Horizon Corporation opened a new position in Exagen (XGN) in Q2 2021: 958 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #621 among its holdings.

54 funds tracked by Wall St. Rank hold XGN as of Q2 2021.

  • First Horizon Corporation held 958 shares of Exagen worth $14K as of Q2 2021.
  • Exagen was a new First Horizon Corporation position in Q2 2021.
  • Exagen made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #621 holding.
  • 54 funds tracked by Wall St. Rank held Exagen as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.